Ajanta Pharma Board Meeting for Q1 FY27 Results

This is a regulatory disclosure filed by Ajanta Pharma Limited pursuant to Regulation 29 of the SEBI Listing Regulations (LODR).

The Board of Directors of the company will hold a meeting on Thursday, 30th July 2026. The primary purpose of this meeting is to consider and approve the following items:

• The unaudited consolidated financial results for the first quarter ended 30th June 2026.
• The unaudited standalone financial results for the first quarter ended 30th June 2026.

The document uses the term "inter-alia," indicating that other matters may also be discussed in the board meeting, though they are not specified in this notice.

The notice was signed and digitally submitted by Gaurang Chinubhai Shah, Sr. VP – Legal & Company Secretary, on 20th July 2026 at 10:29:43 IST.